Senseonics: Eversense 365 Adoption Has To Earn The Valuation

Senseonics, a medical technology company, has launched its Eversense 365 continuous glucose monitoring system. The system, which is implanted under the skin, provides real-time glucose readings for up to 90 days. The launch is expected to have a significant impact on the healthcare industry and could potentially revolutionize the way diabetes is managed.